An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice

The study and treatment of age-related macular degeneration (AMD), a leading cause of blindness, has been hampered by a lack of animal models. Here we report that mice deficient either in monocyte chemoattractant protein-1 (Ccl-2; also known as MCP-1) or its cognate C-C chemokine receptor-2 (Ccr-2) develop cardinal features of AMD, including accumulation of lipofuscin in and drusen beneath the retinal pigmented epithelium (RPE), photoreceptor atrophy and choroidal neovascularization (CNV). Complement and IgG deposition in RPE and choroid accompanies senescence in this model, as in human AMD. RPE or choroidal endothelial production of Ccl-2 induced by complement C5a and IgG may mediate choroidal macrophage infiltration into aged wild-type choroids. Wild-type choroidal macrophages degrade C5 and IgG in eye sections of Ccl2−/− or Ccr2−/− mice. Impaired macrophage recruitment may allow accumulation of C5a and IgG, which induces vascular endothelial growth factor (VEGF) production by RPE, possibly mediating development of CNV. These models implicate macrophage dysfunction in AMD pathogenesis and may be useful as a platform for validating therapies.

[1]  C. Curcio,et al.  Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. , 2000, Investigative ophthalmology & visual science.

[2]  R. Bucala,et al.  Advanced glycation end products increase retinal vascular endothelial growth factor expression. , 1998, The Journal of clinical investigation.

[3]  G. Hageman,et al.  Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.

[4]  A. Mantovani,et al.  Beta-amyloid (25-35) peptide and IFN-gamma synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells. , 1996, Journal of immunology.

[5]  P. Wiedemann,et al.  Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[6]  G. Palade,et al.  Neovasculature induced by vascular endothelial growth factor is fenestrated. , 1997, Cancer research.

[7]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  W R Green,et al.  Age-related Macular Degeneration Histopathologic Studies: The 1992 Lorenz E. Zimmerman Lecture , 1993, Ophthalmology.

[9]  E. de Juan,et al.  Age-related retinal pigment epithelium and Bruch's membrane degeneration in senescence-accelerated mouse. , 2000, Investigative ophthalmology & visual science.

[10]  K. Ley,et al.  Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Eldred,et al.  Retinal age pigments generated by self-assembling lysosomotropic detergents , 1993, Nature.

[12]  L. V. Johnson,et al.  A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.

[13]  I. Constable,et al.  Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. , 2002, The American journal of pathology.

[14]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[15]  P. Campochiaro,et al.  Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. , 1998, The American journal of pathology.

[16]  J. Heckenlively.  Autoantibodies to retinal astrocytes associated with age-related macular degeneration , 1991 .

[17]  K. Csaky,et al.  Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor. , 2000, Investigative ophthalmology & visual science.

[18]  I J Constable,et al.  Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. , 2000, The American journal of pathology.

[19]  P. J. Baker,et al.  Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. , 1993, The American journal of pathology.

[20]  M. Kamei,et al.  TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. , 1999, Investigative ophthalmology & visual science.

[21]  S. Horiuchi,et al.  Advanced glycation end products in age-related macular degeneration. , 1998, Archives of ophthalmology.

[22]  Joan W. Miller,et al.  Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[23]  D. Birch,et al.  Insights into the Function of Rim Protein in Photoreceptors and Etiology of Stargardt's Disease from the Phenotype in abcr Knockout Mice , 1999, Cell.

[24]  H. Katus,et al.  Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. , 2000, Circulation.

[25]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[26]  M. Tso,et al.  Antiretinal antibodies in serum of patients with age-related macular degeneration. , 1991, Ophthalmology.

[27]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[28]  R. Strieter,et al.  Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cells , 1996, Journal of leukocyte biology.

[29]  M. Tso,et al.  Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study. , 1985, Archives of ophthalmology.

[30]  B. Rollins,et al.  Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.

[31]  Scott W Cousins,et al.  The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. , 2002, Experimental eye research.

[32]  M. Gillies,et al.  Immunological and Aetiological Aspects of Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[33]  Andreas Wenzel,et al.  Age-related Macular Degeneration , 2000, The Journal of Biological Chemistry.

[34]  C K Dorey,et al.  Autofluorescence distribution associated with drusen in age-related macular degeneration. , 2000, Investigative ophthalmology & visual science.

[35]  A Hofman,et al.  Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.

[36]  N. D. de Boer,et al.  Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis , 2001, Annals of the rheumatic diseases.

[37]  M. Nishimura,et al.  Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration? , 2003, The British journal of ophthalmology.

[38]  C. Galván,et al.  Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. , 2002, Archives of ophthalmology.

[39]  P. Ward,et al.  Expression and Function of the C5a Receptor in Rat Alveolar Epithelial Cells1 , 2002, The Journal of Immunology.

[40]  C. Curcio,et al.  Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. , 2001, Archives of ophthalmology.

[41]  R. D'Amato,et al.  Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. , 2001, The American journal of pathology.

[42]  J. Ambati,et al.  Macrophage depletion inhibits experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[43]  E. Rodriguez-Boulan,et al.  The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Grossniklaus,et al.  Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. , 2002, Molecular vision.

[45]  Sonia H Yoo,et al.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. , 2003, Survey of ophthalmology.

[46]  S. Ryan,et al.  Subretinal neovascularization. Natural history of an experimental model. , 1982, Archives of ophthalmology.